[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The World Anesthesia Drug Market (General, Local, Adjunctive)

March 2012 | 190 pages | ID: W6B72565736EN
Kalorama Information

US$ 3,995.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:
  • General Anesthesia
  • Local Anesthesia
  • Adjunctive Therapies in Anesthesia

The report covers both currently marketed and late stage development anesthesia drugs. For each of these segments the report contains:
  • Products on the Market
  • Products in Development
  • Market Size and Forecast
  • Market Share of Key Players
  • Issues and Trends

Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. Product chapters in this report provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

There are several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which are probably one of the most important aspects of the administration of anesthetic agents. This industry is a mature industry so it does not have the typical competitive issues often seen in other pharmaceutical segments. However, there are some issues that concern research and development of promising areas in anesthesia.
ONE: EXECUTIVE SUMMARY

Introduction
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors

TWO: INTRODUCTION

Introduction and History to Anesthesia Drugs
Types of Anesthesia
  General Anesthesia
  Local Anesthesia
  Adjunctive Therapies in Anesthesia
Routes of Administration
  Inhalation
  Mask Inhalation
  Laryngeal Mask
  Endotracheal Administration
  Controlled Respiration
  Intravenous
  Topical Application
  Transdermal/Transmucosal Application
Distribution Channels
Demographics and Statistics
Medical Procedures by Type
Complications in Anesthesia
Anesthesiology—Work Force

THREE: GENERAL ANESTHESIA

Overview
Stages of General Anesthesia
  Induction
  Excitement
Surgical Anesthesia
Overdose
Description of Products
  Brevital
  Diprivan
  Ethrane
  Forane
  Halothane
  Ketalar
  Lusedra
  Pentothal
  Suprane
  Ultane/Sevorane
Generic Drug Impact and Availability
Research and Development
Market Size and Growth
  Total Market
  Market by Delivery Method
  Market by Geographical Region
Competitive Analysis

FOUR: LOCAL ANESTHESIA

Overview
Techniques of Administration
  Topical Application
  Transdermal/Transmucosal
  Simple Local Infiltration
  Regional Injections
  Spinal and Epidural Anesthesia
  Intrathecal Block
  Epidural, Peridural Block
Description of Products
  Amides
  Carbocaine/Isocaine/Polocaine
  Citanest
  Exparel
  Marcaine/Sensorcaine
  Naropin
  Septocaine
  Xylocaine/LidoSite/Lidoderm
  Esters
  Cocaine Hydrochloride
  Nesacaine
  Novocaine
  Pontocaine
  Combinations
  EMLA
  Pliaglis
  Synera
Generic Drug Impact and Availability
Research and Development
Market Size and Growth
  Total Market
  Market by Delivery Method
  Market by Geographical Region
Competitive Analysis

FIVE: ADJUNCTIVE THERAPIES

Overview
Description of Products
  Neuromuscular Blocking Agents
  Preanesthetic Sedation and Anesthesia Maintenance
  Precedex/dexdor
  Anesthesia Reversal Agents
Generic Drug Impact and Availability
Research and Development
  Bridion (sugammadex)
  Gantacurium
  Remimazolam (CNS 7056)
  Market Size and Growth
Total Market
Market by Geographical Region
Competitive Analysis

SIX: TOTAL MARKET SIZE AND FORECAST

Total Market Size and Forecast
  Anesthesia Market by Product Type
  Anesthesia Market by Geographical Region
Competitor Analysis

SEVEN: ISSUES AND TRENDS

Introduction
Regulation of Anesthesia Drugs
Dentistry and Anesthesia
Anesthesia and Complications in Pediatric Applications
Allergic Reactions in Anesthesia
Propofol Recall
Anesthesia and the Benefits to Depression Patients
Pediatric Studies in Bipolar Disorders
Anesthesia and Sleep
Gender Differences in Anesthesia Reaction
Manufacturing and Supply Issues
Drug Shortages
Propofol
Recreational Use of Anesthetics
Trends in Conscious Sedation
Long-term Effects of Anesthesia
Anesthesia and Numbing Technologies
Sedasys

EIGHT: CORPORATE PROFILES

Introduction
Acquisitions, Alliances and Agreements
Hospira and DURECT Corporation
Hospira and Javelin Pharmaceuticals, Inc.
ZARS Pharma and Nuvo Research, Inc.
Abbott Laboratories
AstraZeneca
Baxter International
Eisai Co., Ltd.
Endo Pharmaceuticals, Inc.
Hospira, Inc.
Merck/Schering-Plough
Roche

APPENDIX: List of Companies

LIST OF TABLES

ONE: EXECUTIVE SUMMARY
Table 1-1: The Total World Market for Anesthesia Drugs 2007-2016
Figure 1-1: The Total Market for Anesthesia Drugs 2007-2016
TWO: INTRODUCTION
Table 2-1: World Population by Selected Geographical Region, 2010 - 2050
Figure 2-1: World Population by Selected Geographical Region, 2010–2050
Table 2-2: Procedures by Type, Average Annually 2007-2011
Figure 2-2: Procedures by Type Worldwide, Average Annually 2007-2011
Figure 2-3: Procedures by Type U.S., Average Annually 2007-2011
Table 2-3: Worldwide Anesthesia Complications
Table 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year
Figure 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year
THREE: GENERAL ANESTHESIA
Table 3-1: Marketed Brands for General Anesthesia Drugs (Brand Name, Generic Name, and Supplier)
Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
Table 3-3: Brand vs. Generic General Anesthetic Market 2007-2011
Table 3-4: The Market for General Anesthesia Drugs 2007-2016
Figure 3-1: The Market for General Anesthesia Drugs 2007-2016
Figure 3-2: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2011
Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011
Figure 3-3: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2011
Table 3-6: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011
Figure 3-4: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2011
FOUR: LOCAL ANESTHESIA
Table 4-1: Selected Marketed Local Anesthesia Drugs (Brand Name, Generic Name and Supplier)
Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia
Figure 4-1: Brand vs. Generic Local Anesthetic Market 2007-2011
Table 4-3: Local Anesthesia Drugs in Development
Table 4-4: The Market for Local Anesthesia Drugs 2007-2016
Figure 4-2: The Total Market for Local Anesthesia Drugs 2007-2016
Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2011
Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011
Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2011
Table 4-6: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011
Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2011
FIVE: ADJUNCTIVE THERAPIES
Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia (Type, Brand Name, Generic Name, and Supplier)
Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2007-2011
Table 5-3: Adjunctive Therapies in Anesthesia in Development
Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2007-2016
Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2007-2016
Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2011
Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2011
Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2009-2011
Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2011
SIX: TOTAL MARKET AND FORECAST
Table 6-1: The Total World Market for Anesthesia Drugs 2007-2016
Figure 6-1: The Total Market for Anesthesia Drugs 2007-2016
Table 6-2: Anesthesia Drug Market by Type 2007-2016
Figure 6-2: Anesthesia Drug Market by Type 2007-2016
Figure 6-3: Anesthesia Drug Market by Type 2011
Figure 6-4: Anesthesia Drug Market by Type 2016
Table 6-3: Anesthesia Drug Market Estimated Products Sales by Geographic Region, 2011
Figure 6-5: Anesthesia Drug Market Market Share by Geographic Region, 2011
Table 6-4: Leading Suppliers Anesthesia Revenues and Significant Segments of Participation, 2011
Figure 6-6: Leading Suppliers—Anesthesia Revenues, 2011


More Publications